Frank Svoboda Biography and Net Worth

Co-Chairman and Chief Executive Officer of Globe Life


Frank M. Svoboda serves as Chief Financial Officer, Executive Vice President, President of Globe of the Company. He served as President of Globe since July 2018. (President of American Income Jan. 2017 - July 2018)

What is Frank M. Svoboda's net worth?

The estimated net worth of Frank M. Svoboda is at least $4.28 million as of July 31st, 2025. Mr. Svoboda owns 32,747 shares of Globe Life stock worth more than $4,284,683 as of December 4th. This net worth approximation does not reflect any other assets that Mr. Svoboda may own. Additionally, Mr. Svoboda receives an annual salary of $2,450,000.00 as Co-Chairman and Chief Executive Officer at Globe Life. Learn More about Frank M. Svoboda's net worth.

How old is Frank M. Svoboda?

Mr. Svoboda is currently 62 years old. There are 9 older executives and no younger executives at Globe Life. Learn More on Frank M. Svoboda's age.

What is Frank M. Svoboda's salary?

As the Co-Chairman and Chief Executive Officer of Globe Life Inc., Mr. Svoboda earns $2,450,000.00 per year. Learn More on Frank M. Svoboda's salary.

How do I contact Frank M. Svoboda?

The corporate mailing address for Mr. Svoboda and other Globe Life executives is 3700 South Stonebridge Drive, McKinney TX, 75070. Globe Life can also be reached via phone at (972) 569-4000 and via email at [email protected]. Learn More on Frank M. Svoboda's contact information.

Has Frank M. Svoboda been buying or selling shares of Globe Life?

Frank M. Svoboda has not been actively trading shares of Globe Life in the last ninety days. Most recently, Frank M. Svoboda sold 12,500 shares of the business's stock in a transaction on Thursday, July 31st. The shares were sold at an average price of $141.38, for a transaction totalling $1,767,250.00. Following the completion of the sale, the chief executive officer now directly owns 32,747 shares of the company's stock, valued at $4,629,770.86. Learn More on Frank M. Svoboda's trading history.

Who are Globe Life's active insiders?

Globe Life's insider roster includes Charles Adair (Director), Cheryl Alston (Director), Jane Buchan (Director), Jane Buchan (Director), Gary Coleman (CEO), James Darden (CEO), Steven DiChiaro (Insider), Steven Greer (Insider), Jennifer Haworth (CMO), Michael Henrie (CAO), Robert Hensley (EVP), Larry Hutchison (CEO), Robert Ingram (Director), Thomas Kalmbach (CFO), Michael Majors (EVP), Kenneth Matson (Insider), James McPartland (EVP), Robert Mitchell (EVP), Christopher Moore (SVP), W. Pressley (EVP), David Rodriguez (Director), Frank Svoboda (Co-Chairman and Chief Executive Officer), Mary Thigpen (Director), and Rebecca Zorn (EVP). Learn More on Globe Life's active insiders.

Are insiders buying or selling shares of Globe Life?

In the last twelve months, insiders at the sold shares 10 times. They sold a total of 152,079 shares worth more than $19,710,810.11. The most recent insider tranaction occured on August, 1st when EVP Michael Clay Majors sold 10,000 shares worth more than $1,374,100.00. Insiders at Globe Life own 1.5% of the company. Learn More about insider trades at Globe Life.

Information on this page was last updated on 8/1/2025.

Frank M. Svoboda Insider Trading History at Globe Life

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/31/2025Sell12,500$141.38$1,767,250.0032,747View SEC Filing Icon  
5/20/2025Sell6,019$122.51$737,387.6931,298View SEC Filing Icon  
2/13/2025Sell11,000$122.31$1,345,410.0018,948View SEC Filing Icon  
1/6/2025Sell13,448$112.56$1,513,706.8818,948View SEC Filing Icon  
12/3/2024Sell14,340$108.80$1,560,192.0016,396View SEC Filing Icon  
11/17/2023Sell9,500$118.22$1,123,090.003,370View SEC Filing Icon  
11/6/2023Sell20,000$115.92$2,318,400.003,370View SEC Filing Icon  
8/16/2023Sell12,500$113.57$1,419,625.003,370View SEC Filing Icon  
2/28/2023Sell10,000$121.36$1,213,600.003,370View SEC Filing Icon  
2/24/2023Sell10,000$121.26$1,212,600.003,370View SEC Filing Icon  
5/21/2021Sell20,000$105.11$2,102,200.0020,000View SEC Filing Icon  
5/5/2021Sell15,000$104.50$1,567,500.0015,000View SEC Filing Icon  
4/29/2021Sell15,000$102.94$1,544,100.0015,000View SEC Filing Icon  
3/1/2021Sell15,000$95.38$1,430,700.0015,000View SEC Filing Icon  
11/3/2020Sell20,000$84.94$1,698,800.0020,000View SEC Filing Icon  
7/29/2020Sell8,050$80.25$646,012.5010,000View SEC Filing Icon  
2/11/2020Sell5,000$109.44$547,200.0015,000View SEC Filing Icon  
11/15/2019Sell10,000$99.67$996,700.00116,533View SEC Filing Icon  
11/13/2019Sell10,000$99.04$990,400.00116,533View SEC Filing Icon  
7/31/2019Sell11,250$91.85$1,033,312.50117,783View SEC Filing Icon  
See Full Table

Frank M. Svoboda Buying and Selling Activity at Globe Life

This chart shows Frank M Svoboda's buying and selling at Globe Life by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Globe Life Company Overview

Globe Life logo
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. It offers whole, term, and other life insurance products; Medicare supplement and supplemental health insurance products, such as accident, cancer, critical illness, heart, and intensive care plans; and single-premium and flexible-premium deferred annuities. The company sells its products through its direct to consumer division, exclusive agencies, and independent agents. The company was formerly known as Torchmark Corporation and changed its name to Globe Life Inc. in August 2019. Globe Life Inc. was founded in 1900 and is headquartered in McKinney, Texas.
Read More

Today's Range

Now: $130.84
Low: $130.27
High: $132.02

50 Day Range

MA: $134.61
Low: $130.37
High: $144.48

2 Week Range

Now: $130.84
Low: $100.62
High: $147.83

Volume

300,396 shs

Average Volume

468,810 shs

Market Capitalization

$10.42 billion

P/E Ratio

9.48

Dividend Yield

0.83%

Beta

0.48